 |
 |
 |
 |
 |
|
experimental hepatologySelected PublicationsSOBREVALS L, RODRIGUEZ C, ROMERO-TREVEJO JL, GONDI G, MONREAL I, PAŃEDA A, JUANARENA N, ARCELUS S, RAZQUIN N, GUEMBE L, GONZÁLEZ-ASEGUINOLAZA G, PRIETO J, FORTES P. Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats. Hepatology. 2010 Mar;51(3):912-21.
ABSTRACT COURTESY OF PUBMEDPARDO-SAGANTA A, LATASA MU, CASTILLO J, ALVAREZ-ASIAIN L, PERUGORRÍA MJ, SAROBE P, RODRIGUEZ-ORTIGOSA CM, PRIETO J, BERASAIN C, SANTAMARÍA M, AVILA MA. The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression. J Hepatol. 2009 Dec;51(6):1010-20. Epub 2009 Sep 12. ABSTRACT COURTESY OF PUBMEDTUTAU F, RODRÍGUEZ-ORTIGOSA C, PUCHE JE, JUANARENA N, MONREAL I, GARCÍA FERNÁNDEZ M, CLAVIJO E, CASTILLA A, CASTILLA-CORTÁZAR I. Enhanced actions of insulin-like growth factor-I and interferon-alpha co-administration in experimental cirrhosis. Liver Int. 2009 Jan;29(1):37-46. Epub 2008 Jun 9.
ABSTRACT COURTESY OF PUBMEDLORENZO-ZÚŃIGA V, RODRÍGUEZ-ORTIGOSA CM, BARTOLÍ R, MARTÍNEZ-CHANTAR ML, MARTÍNEZ-PERALTA L, PARDO A, OJANGUREN I, QUIROGA J, PLANAS R, PRIETO J. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut. 2006 Sep;55(9):1306-12. Epub 2006 Jan 24. ABSTRACT COURTESY OF PUBMED |
|
|